About UCSF Search UCSF UCSF Medical Center

Marc A. Shuman, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
shuman_marc

Professor, Departments of Medicine and Urology, UCSF

shuman@medicine.ucsf.edu

Phone: (415) 476-2125 (voice)
Box 1270, UCSF
San Francisco, CA 94143-1270

View on UCSF Profiles


Education

University of Wisconsin, Madison Madison, WI, B.S., 1962, Philosophy/Chemistry
University of PA, Philadelphia Philadelphia, PA, Biology
Thomas Jefferson Medical College Philadelphia, PA, M.D., 1967, Medicine


Professional Experience

  • 1967-1968
    Intern, Pennsylvania Hospital, Philadelphia
  • 1968-1969
    Junior Assistant Resident, Hospital of the University of Pennsylvania, Philadelphia
  • 1971-1972
    Senior Resident, Department of Medicine, Hospital of the University of Pennsylvania, Phila.
  • 1972-1973
    Clinical Fellow, Division of Hematology-Oncology, Washington University, St. Louis, MO
  • 1973-1976
    Postdoctoral Fellow, Division of Hematology-Oncology, Washington University, St. Louis, MO
  • 1976-1981
    Assistant Professor of Medicine, University of California, San Francisco
  • 1981-1986
    Associate Professor of Medicine, University of California, San Francisco
  • 1986-present
    Professor of Medicine, University of California, San Francisco
  • 1989-present
    Chief of Hematology, Division of Hematology-Oncology, UCSF
  • 1992-1996
    Interim Director, Cancer Research Institute, UCSF
  • 1996-2004
    Associate Director, Cancer Research Institute, UCSF
  • 1997-2000
    Chief of Oncology, Division of Hematology-Oncology, UCSF
  • 1997-2007
    Associate Director for Program Development, UCSF Helen Diller Family Comprehensive Cancer Center
  • 1997-2007
    Director, Prostate Cancer Program, UCSF Helen Diller Family Comprehensive Cancer Center
  • 1997-present
    Executive Committee, UCSF Helen Diller Family Comprehensive Cancer Center
  • 1999-present
    Professor of Urology, University of California, San Francisco
  • 2005-present
    Clinical Director, California Institute for Quantitative Biomedical Research (QB3), San Francisco, CA

Honors & Awards

  • 1980
    Elected to American Society of Clinical Investigation
  • 1981
    Awarded Research Career Development Award, National Institutes of Health
  • 1989
    Elected to Association of American Physicians

Selected Publications

  1. Rubenstein JL, Li J, Chen L, Advani R, Drappatz J, Gerstner E, Batchelor T, Krouwer H, Hwang J, Auerback G, Kadoch C, Lowell C, Munster P, Cha S, Shuman MA, Damon LE. Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Blood. 2013 Jan 31; 121(5):745-51.
    View on PubMed
  2. Huang X, Dubuc AM, Hashizume R, Berg J, He Y, Wang J, Chiang C, Cooper MK, Northcott PA, Taylor MD, Barnes MJ, Tihan T, Chen J, Hackett CS, Weiss WA, James CD, Rowitch DH, Shuman MA, Jan YN, Jan LY. Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev. 2012 Aug 15; 26(16):1780-96.
    View on PubMed
  3. Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res. 2012 Feb 15; 18(4):1146-55.
    View on PubMed
  4. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2012 Feb; 40(4):1695-707.
    View on PubMed
  5. Sun C, Su KH, Valentine J, Rosa-Bauza YT, Ellman JA, Elboudwarej O, Mukherjee B, Craik CS, Shuman MA, Chen FF, Zhang X. Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensors. ACS Nano. 2010 Feb 23; 4(2):978-84.
    View on PubMed
  6. So AY, de la Fuente E, Walter P, Shuman M, Bernales S. The unfolded protein response during prostate cancer development. Cancer Metastasis Rev. 2009 Jun; 28(1-2):219-23.
    View on PubMed
  7. Kadoch C, Dinca EB, Voicu R, Chen L, Nguyen D, Parikh S, Karrim J, Shuman MA, Lowell CA, Treseler PA, James CD, Rubenstein JL. Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model. Clin Cancer Res. 2009 Mar 15; 15(6):1989-97.
    View on PubMed
  8. Rubenstein JL, Shen A, Batchelor TT, Kadoch C, Treseler P, Shuman MA. Differential gene expression in central nervous system lymphoma. Blood. 2009 Jan 1; 113(1):266-7; author reply 267-8.
    View on PubMed
  9. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL. Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol. 2008 Jan 1; 26(1):96-105.
    View on PubMed
  10. Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol. 2007 Apr 10; 25(11):1350-6.
    View on PubMed
  11. Chan JM, Feraco A, Shuman M, Hernández-Díaz S. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. Hematol Oncol Clin North Am. 2006 Aug; 20(4):797-809.
    View on PubMed
  12. Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M. Gene expression and angiotropism in primary CNS lymphoma. Blood. 2006 May 1; 107(9):3716-23.
    View on PubMed
  13. Tindall D, Horne FM, Hruszkewycz A, Mohla S, Shuman M, Wang Z, Kantoff P. Symposium on androgen action in prostate cancer. Cancer Res. 2004 Oct 1; 64(19):7178-80.
    View on PubMed
  14. Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med. 2004 Jan 26; 164(2):218-20.
    View on PubMed
  15. Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA, Craik CS. Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biol Chem. 2003 Feb; 384(2):257-66.
    View on PubMed
  16. Bok RA, Hansell EJ, Nguyen TP, Greenberg NM, McKerrow JH, Shuman MA. Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model. Prostate Cancer Prostatic Dis. 2003; 6(4):272-80.
    View on PubMed
  17. Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D, Grillo-Lopez A, Shuman MA. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003 Jan 15; 101(2):466-8.
    View on PubMed
  18. Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol. 2002 May; 58(1):53-6.
    View on PubMed
  19. Elfman F, Bok R, Conn M, Shuman M, Cunha G. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate. Differentiation. 2001 Dec; 69(2-3):108-20.
    View on PubMed
  20. Bok RA, Halabi S, Fei DT, Rodriquez CR, Hayes DF, Vogelzang NJ, Kantoff P, Shuman MA, Small EJ. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res. 2001 Mar 15; 61(6):2533-6.
    View on PubMed

Go to UCSF Profiles, powered by CTSI